Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012368763> ?p ?o ?g. }
- W2012368763 endingPage "158" @default.
- W2012368763 startingPage "151" @default.
- W2012368763 abstract "Peroxisome proliferator-activated receptor (PPAR) γ agonists are used clinically for treating diabetes mellitus and cancer. 2-Methyl-2[(1-{3-phenyl-7-propylbenzol[d]isoxazol-6-yl}oxy)propyl]-1H-4-indolyl) oxy]propanoic acid (BPR1H0101) is a novel synthetic indole-based compound, discovered through research to identify new PPARγ agonists, and it acts as a dual agonist for PPARγ and PPARα. Isobologram analysis demonstrated that BPR1H0101 is capable of antagonistic interaction with the topoisomerase (topo) II poison, VP16. A study of its mechanism showed that BPR1H0101 could inhibit the catalytic activity of topo II in vitro, but did not produce detectable topo II-mediated DNA strand breaks in human oral cancer KB cells. Furthermore, BPR1H0101 could inhibit VP16-induced topo II-mediated DNA cleavage and ataxia-telangiectasia-mutated phosphorylation in KB cells. The results suggest that BPR1H0101 can interfere with the topo II reaction by inhibiting catalytic activity before the formation of the intermediate cleavable complex; consequently, it can impede VP16-induced topo II-mediated DNA cleavage and cell death. This is the first identified PPARα/γ agonist that can serve as a topo II catalytic inhibitor, to interfere with VP16-induced cell death. The result might have relevance to the clinical use of the PPARα/γ agonist in combination chemotherapy." @default.
- W2012368763 created "2016-06-24" @default.
- W2012368763 creator A5004593619 @default.
- W2012368763 creator A5007474173 @default.
- W2012368763 creator A5013458259 @default.
- W2012368763 creator A5015999780 @default.
- W2012368763 creator A5016600808 @default.
- W2012368763 creator A5046572350 @default.
- W2012368763 creator A5052252515 @default.
- W2012368763 creator A5060462482 @default.
- W2012368763 creator A5066336290 @default.
- W2012368763 date "2008-02-01" @default.
- W2012368763 modified "2023-09-23" @default.
- W2012368763 title "A novel peroxisome proliferator-activated receptor α/γ agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells" @default.
- W2012368763 cites W1543261346 @default.
- W2012368763 cites W1608005125 @default.
- W2012368763 cites W1925149569 @default.
- W2012368763 cites W1975927677 @default.
- W2012368763 cites W1976962732 @default.
- W2012368763 cites W1977206378 @default.
- W2012368763 cites W1983128420 @default.
- W2012368763 cites W1984304064 @default.
- W2012368763 cites W1989050470 @default.
- W2012368763 cites W1993342645 @default.
- W2012368763 cites W1995574334 @default.
- W2012368763 cites W2002519246 @default.
- W2012368763 cites W2005562492 @default.
- W2012368763 cites W2010511880 @default.
- W2012368763 cites W2010676078 @default.
- W2012368763 cites W2016952673 @default.
- W2012368763 cites W2024322753 @default.
- W2012368763 cites W2027702484 @default.
- W2012368763 cites W2030295874 @default.
- W2012368763 cites W2054917141 @default.
- W2012368763 cites W2056367986 @default.
- W2012368763 cites W2058763582 @default.
- W2012368763 cites W2060529266 @default.
- W2012368763 cites W2087310793 @default.
- W2012368763 cites W2088144835 @default.
- W2012368763 cites W2102345056 @default.
- W2012368763 cites W2102752109 @default.
- W2012368763 cites W2102998952 @default.
- W2012368763 cites W2109689528 @default.
- W2012368763 cites W2118316875 @default.
- W2012368763 cites W2124624490 @default.
- W2012368763 cites W2132600317 @default.
- W2012368763 cites W2140603676 @default.
- W2012368763 cites W2151096273 @default.
- W2012368763 cites W2165886365 @default.
- W2012368763 cites W4233567369 @default.
- W2012368763 cites W4242306912 @default.
- W2012368763 doi "https://doi.org/10.1097/cad.0b013e3282f28fe" @default.
- W2012368763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18176111" @default.
- W2012368763 hasPublicationYear "2008" @default.
- W2012368763 type Work @default.
- W2012368763 sameAs 2012368763 @default.
- W2012368763 citedByCount "7" @default.
- W2012368763 countsByYear W20123687632012 @default.
- W2012368763 countsByYear W20123687632013 @default.
- W2012368763 countsByYear W20123687632016 @default.
- W2012368763 countsByYear W20123687632018 @default.
- W2012368763 crossrefType "journal-article" @default.
- W2012368763 hasAuthorship W2012368763A5004593619 @default.
- W2012368763 hasAuthorship W2012368763A5007474173 @default.
- W2012368763 hasAuthorship W2012368763A5013458259 @default.
- W2012368763 hasAuthorship W2012368763A5015999780 @default.
- W2012368763 hasAuthorship W2012368763A5016600808 @default.
- W2012368763 hasAuthorship W2012368763A5046572350 @default.
- W2012368763 hasAuthorship W2012368763A5052252515 @default.
- W2012368763 hasAuthorship W2012368763A5060462482 @default.
- W2012368763 hasAuthorship W2012368763A5066336290 @default.
- W2012368763 hasConcept C121608353 @default.
- W2012368763 hasConcept C127078168 @default.
- W2012368763 hasConcept C147897179 @default.
- W2012368763 hasConcept C170493617 @default.
- W2012368763 hasConcept C185592680 @default.
- W2012368763 hasConcept C187345961 @default.
- W2012368763 hasConcept C202751555 @default.
- W2012368763 hasConcept C2778938600 @default.
- W2012368763 hasConcept C502942594 @default.
- W2012368763 hasConcept C54355233 @default.
- W2012368763 hasConcept C55493867 @default.
- W2012368763 hasConcept C86803240 @default.
- W2012368763 hasConcept C96232424 @default.
- W2012368763 hasConceptScore W2012368763C121608353 @default.
- W2012368763 hasConceptScore W2012368763C127078168 @default.
- W2012368763 hasConceptScore W2012368763C147897179 @default.
- W2012368763 hasConceptScore W2012368763C170493617 @default.
- W2012368763 hasConceptScore W2012368763C185592680 @default.
- W2012368763 hasConceptScore W2012368763C187345961 @default.
- W2012368763 hasConceptScore W2012368763C202751555 @default.
- W2012368763 hasConceptScore W2012368763C2778938600 @default.
- W2012368763 hasConceptScore W2012368763C502942594 @default.
- W2012368763 hasConceptScore W2012368763C54355233 @default.
- W2012368763 hasConceptScore W2012368763C55493867 @default.
- W2012368763 hasConceptScore W2012368763C86803240 @default.
- W2012368763 hasConceptScore W2012368763C96232424 @default.
- W2012368763 hasIssue "2" @default.